Using flow cytometry analysis, we thus evaluated the impact of SVX treatment on the frequencies and phenotypes of CD8+ T cells, CD4+ FoxP3− Tconv, and CD4+ FoxP3+ Treg cells both in the spleen and among tumor infiltrating lymphocytes (TILs) (Figures 6A,B) of TB mice vaccinated or not with SVX but also in TF mice. This evidence concerns the gene CD4 and neoplasm.